Current Affairs

Nice article by Dr. Anil Parwani, Professor of Pathology and Biomedical Informatics at The Ohio State University Wexner Medical Center, where he also serves as the Vice Chair of Anatomic Pathology as well as Director of Pathology Informatics...

Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach. A billion dollars sounds like a lot of money. But when your ambitions are as big as the...

This story from GE Reports was originally published during RSNA last year to help promote their new mammography equipment and referenced the good work being done at Gustave Roussy Cancer Center in a southern suburb of Paris.  But same day...

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...

I received a lot of feedback offline about Part 1 of this post (see: “To Sign Out or Not to Sign Out? Part 1” ) from a number of pathologists echoing my sentiments on the issue of turnaround time in general and needs/expectations from...

This kind of news seems to come up with some regular frequency - "To screen or not to screen, that is the question". This Danish study recently reported in the Annals of Internal Medicine found that screening was not associated with a lower...